PhD S. Bendifallah MD

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The European Society of Medical Oncology (ESMO)/European Society of Gynaecological Oncology (ESGO)/European Society for Radiotherapy & Oncology (ESTRO) classification for endometrial cancer (EC) now includes a high–intermediate risk (HIR) group of recurrence due to the adverse prognostic role of lymphovascular space involvement (LVSI) and grade 3 for women(More)
  • 1